| Bivariate |  | Adjusted |  |
---|---|---|---|---|
Characteristics | Coeff (95% CI) | p-value | Adj.sq.Coeff (95% CI) | p-value |
Intervention group | 0.2 (−0.6;−0.9) | 0.69 |  |  |
Female gender | −3.0 (−3.8;−2.3) | <0.001 |  |  |
Age <35 years | −0.3 (−1.1;−0.6) | 0.54 |  |  |
Severe HIV (clinical stage 3 or 4) | −2.1 (−2.8;−1.4) | <0.001 |  |  |
History of IDU | −2.1 (−2.8;−1.4) | <0.001 |  |  |
ART-non-naïve status | 0.8 (−0.8;2.5) | 0.32 |  |  |
TB history | −0.2 (−1.2;0.8) | 0.68 |  |  |
VL at baseline ≥100,000 copies/ml | −2.8 (−3.6;−2.0) | <0.001 | −0.9 (−1.5;−0.3) | <0.01 |
CD4 at baseline <100 cells/μl | −6.8 (−7.4;−6.3) | <0.001 | −5.7 (−6.3;−5.1) | <0.001 |
Having an HIV-infected family member | 2.5 (1.8;3.3) | <0.001 | 1.3 (0.8;1.9) | <0.001 |
From Ha long CDC OPC | −0.5 (−1.2;0.3) | 0.22 |  |  |
History of OIs | 1.1 (0.3;1.9) | <0.01 | Â | Â |
Changed ART regimen | 1.0 (0.1;1.8) | <0.05 | Â | Â |
Incomplete adherence (missing more than one doses in 24 months) | −1.3 (−3.1;0.5) | 0.15 |  |  |
Month | 0.4 (0.4;0.4) | <0.001 | 0.39 (0.38;0.41) | <0.001 |